Status:
ACTIVE_NOT_RECRUITING
Extending and Banding the Roux-en-Y Gastric Bypass
Lead Sponsor:
Rijnstate Hospital
Conditions:
Morbid Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The Roux-en-Y gastric bypass (RYGB) has proven to be an effective treatment for morbid obesity by reducing weight and comorbidities. Extending the pouch may improve weightloss without the increase of ...
Detailed Description
The Roux-en-Y gastric bypass (RYGB) has proven to be an effective treatment for morbid obesity by reducing weight and comorbidities. Extending the pouch may improve weightloss without the increase of ...
Eligibility Criteria
Inclusion
- All patients who are eligible for a primary RYGB
Exclusion
- Bariatric surgery in medical history
- Patients with a language barrier which may affect the compliance with medical advice
- Patients with a disease not related to morbid obesity, such as Cushing or drug related.
- Chronic bowel disease for example Crohn's disease or colitis Colitis.
- Renal impairment (MDRD \<30)
- Hepatic dysfunction (liver function twice the normal values)
- Pregnancy during follow-up
- Patients with treatment-resistant reflux symptoms.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2028
Estimated Enrollment :
375 Patients enrolled
Trial Details
Trial ID
NCT05357807
Start Date
March 1 2021
End Date
March 1 2028
Last Update
June 21 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Rijnstate Hospital
Arnhem, Gelderland, Netherlands, 6815AD
2
St. Antonius Ziekenhuis
Nieuwegein, Utrecht, Netherlands, 3435CM
3
NOK West
The Hague, Netherlands